EpicentRx, Inc.

EpicentRx, Inc.

Biotechnology Research

La Jolla, CA 820 followers

The future starts today

About us

EpicentRx is an innovation-driven clinical-stage drug and device company that puts the emphasis on “ease” - ease of treatment, ease of side effects, and ease of symptoms during the treatment of a range of diseases including lung cancer, and head and neck cancer, and different inflammatory disorders for which the company has received several grants and orphan designations. The lead device is called the eLOOP and the lead therapies are the direct NLRP3 inhibitor, nibrozetone (RRx-001), and the TGF-β trap-enhanced oncolytic adenovirus, AdAPT-001, in Phase 3, and Phase 2 clinical trials, respectively.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
La Jolla, CA
Type
Privately Held

Locations

  • Primary

    11099 North Torrey Pines Road

    Suite 160

    La Jolla, CA 92037, US

    Get directions

Employees at EpicentRx, Inc.

Updates

Similar pages

Browse jobs

Funding

EpicentRx, Inc. 2 total rounds

Last Round

Grant

US$ 500.0K

See more info on crunchbase